Detalles de la búsqueda
1.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-ß2 levels in metastatic colorectal cancer patients (Alliance).
BMC Genomics
; 25(1): 473, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745123
2.
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
Breast Cancer Res Treat
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38872062
3.
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer.
Oncologist
; 28(3): e171-e174, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779536
4.
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Int J Cancer
; 150(2): 279-289, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34528705
5.
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance).
Angiogenesis
; 25(1): 47-55, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028627
6.
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Br J Cancer
; 126(2): 265-274, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616010
7.
PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors.
Pharmacogenomics J
; 22(1): 82-88, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775477
8.
KDR genetic predictor of toxicities induced by sorafenib and regorafenib.
Pharmacogenomics J
; 22(5-6): 251-257, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484400
9.
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitors.
Br J Clin Pharmacol
; 88(9): 4171-4179, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437784
10.
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
BMC Cancer
; 21(1): 575, 2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011306
11.
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.
J Clin Pharm Ther
; 44(3): 415-419, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666679
12.
Cisplatin-induced human peripheral blood mononuclear cells' oxidative stress and nephrotoxicity in head and neck cancer patients: the influence of hydrogen peroxide.
Mol Cell Biochem
; 440(1-2): 139-145, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28828710
13.
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Br J Cancer
; 126(1): 162, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34853435
14.
Correction to: PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors.
Pharmacogenomics J
; 22(2): 145, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34934177
15.
Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer.
JCO Precis Oncol
; 8: e2300411, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394466
16.
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
Clin Cancer Res
; 30(4): 836-848, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060240
17.
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
Clin Cancer Res
; 30(8): 1669-1684, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38345769
18.
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer.
Eur Urol Open Sci
; 55: 45-49, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662703
19.
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness.
JCO Precis Oncol
; 7: e2300092, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410975
20.
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients.
Pharmaceuticals (Basel)
; 16(5)2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37242509